• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

怎样才能形成完美的血凝块?

What does it take to make the perfect clot?

作者信息

Monroe Dougald M, Hoffman Maureane

机构信息

Durham Veterans Affairs Medical Center, Department of Pathology, Duke University Medical Center, Durham, NC, USA.

出版信息

Arterioscler Thromb Vasc Biol. 2006 Jan;26(1):41-8. doi: 10.1161/01.ATV.0000193624.28251.83. Epub 2005 Oct 27.

DOI:10.1161/01.ATV.0000193624.28251.83
PMID:16254201
Abstract

The coagulation process has been conceptualized as being primarily dependent on adequate levels of the coagulation proteins. This concept was based on the clear relationship between the bleeding tendency and factor levels in hemophilia. The field is now evolving toward conceptualizing coagulation as being actively regulated by the specialized cellular components of the process. Rather than conceiving coagulation as only a "cascade" of proteolytic reactions, the coagulation reactions occur as overlapping steps on cell surfaces. Components of the old "extrinsic'" and "intrinsic" pathways of coagulation can be thought of as participating in the initiation and propagation of coagulation reactions, respectively. Thus, these pathways are not redundant as they are portrayed in the cascade model, but play distinct and complementary roles. Our understanding of how specific cellular features control the processes of hemostasis and thrombosis is developing rapidly. This review discusses some aspects of the cellular control of coagulation.

摘要

凝血过程在概念上主要被认为依赖于足够水平的凝血蛋白。这一概念基于血友病中出血倾向与因子水平之间的明确关系。现在,该领域正朝着将凝血概念化为由该过程的特殊细胞成分积极调节的方向发展。凝血反应并非仅仅被看作是蛋白水解反应的“级联”,而是在细胞表面以重叠步骤发生。传统凝血“外源性”和“内源性”途径的成分可分别被认为参与凝血反应的启动和传播。因此,这些途径并不像在级联模型中所描述的那样冗余,而是发挥着不同但互补的作用。我们对特定细胞特征如何控制止血和血栓形成过程的理解正在迅速发展。本综述讨论了凝血细胞控制的一些方面。

相似文献

1
What does it take to make the perfect clot?怎样才能形成完美的血凝块?
Arterioscler Thromb Vasc Biol. 2006 Jan;26(1):41-8. doi: 10.1161/01.ATV.0000193624.28251.83. Epub 2005 Oct 27.
2
Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis.血液凝固外源性途径在止血和血栓形成中的作用。
Arterioscler Thromb Vasc Biol. 2007 Aug;27(8):1687-93. doi: 10.1161/ATVBAHA.107.141911. Epub 2007 Jun 7.
3
Rethinking the coagulation cascade.重新审视凝血级联反应。
Curr Hematol Rep. 2005 Sep;4(5):391-6.
4
Tissue factor and tissue factor pathway inhibitor.组织因子与组织因子途径抑制物
Anaesthesia. 2004 May;59(5):483-92. doi: 10.1111/j.1365-2044.2004.03679.x.
5
Recent advances in haemostasis and thrombosis.止血与血栓形成的最新进展。
Retina. 2009 Jan;29(1):1-7. doi: 10.1097/IAE.0b013e31819091dc.
6
Maintenance of homeostasis in coagulation during cardiopulmonary bypass.
J Cardiothorac Vasc Anesth. 1999 Aug;13(4 Suppl 1):2-5; discussion 36-7.
7
Novel roles for factor XII-driven plasma contact activation system.凝血因子XII驱动的血浆接触激活系统的新作用。
Curr Opin Hematol. 2008 Sep;15(5):516-21. doi: 10.1097/MOH.0b013e328309ec85.
8
Standardization and clinical utility of thrombin-generation assays.凝血酶生成试验的标准化及临床应用
Semin Thromb Hemost. 2008 Oct;34(7):670-82. doi: 10.1055/s-0028-1104546. Epub 2008 Dec 15.
9
Role of Factor XII in hemostasis and thrombosis: clinical implications.凝血因子 XII 在止血和血栓形成中的作用:临床意义
Expert Rev Cardiovasc Ther. 2007 Jul;5(4):733-41. doi: 10.1586/14779072.5.4.733.
10
New models of hemostasis.止血新模型。
Top Companion Anim Med. 2012 May;27(2):40-5. doi: 10.1053/j.tcam.2012.07.005. Epub 2012 Aug 29.

引用本文的文献

1
Correlation analyses between MIBG myocardial scintigraphy and monoamine levels in dementia with Lewy bodies show potential link with the serotonergic system.路易体痴呆患者中MIBG心肌闪烁显像与单胺水平的相关性分析显示与血清素能系统存在潜在联系。
Clin Park Relat Disord. 2025 May 12;12:100346. doi: 10.1016/j.prdoa.2025.100346. eCollection 2025.
2
Nonsense Mutations in Rare and Ultra-Rare Human Disorders: An Overview.罕见和超罕见人类疾病中的无义突变:概述
IUBMB Life. 2025 Jun;77(6):e70031. doi: 10.1002/iub.70031.
3
Association between fibrinogen levels and prognosis in critically bleeding patients: exploration of the optimal therapeutic threshold.
严重出血患者纤维蛋白原水平与预后的关系:最佳治疗阈值的探索
Eur J Trauma Emerg Surg. 2025 May 23;51(1):219. doi: 10.1007/s00068-025-02886-8.
4
Reversible High-Affinity Binding of Coagulation Factor Xa to Zeolites Induces Accelerated Blood Coagulation.凝血因子Xa与沸石的可逆高亲和力结合可加速血液凝固。
Adv Sci (Weinh). 2025 Jun;12(22):e2417099. doi: 10.1002/advs.202417099. Epub 2025 Apr 11.
5
Back to basics: the coagulation pathway.回归基础:凝血途径。
Blood Res. 2024 Oct 28;59(1):35. doi: 10.1007/s44313-024-00040-8.
6
Fibrinolysis biomarker, thrombin, and activated protein C level alterations after coagulation activation depend on type of thrombophilia and clinical phenotype.凝血激活后纤维蛋白溶解生物标志物、凝血酶和活化蛋白C水平的改变取决于血栓形成倾向的类型和临床表型。
Res Pract Thromb Haemost. 2024 Feb 15;8(2):102351. doi: 10.1016/j.rpth.2024.102351. eCollection 2024 Feb.
7
Clot or Not? Reviewing the Reciprocal Regulation Between Lipids and Blood Clotting.血栓形成还是不形成?脂质与凝血的相互调节综述。
Arterioscler Thromb Vasc Biol. 2024 Mar;44(3):533-544. doi: 10.1161/ATVBAHA.123.318286. Epub 2024 Jan 18.
8
Hemostatic clots: When modeling goes beyond experimental measurements.止血凝块:当建模超越实验测量时。
Biophys J. 2023 Nov 7;122(21):4121-4122. doi: 10.1016/j.bpj.2023.10.005. Epub 2023 Oct 18.
9
Determination of the Potential Clinical Benefits of Small Molecule Factor XIa Inhibitors in Arterial Thrombosis.小分子凝血因子XIa抑制剂在动脉血栓形成中的潜在临床益处的测定
ACS Pharmacol Transl Sci. 2023 Jun 30;6(7):970-981. doi: 10.1021/acsptsci.3c00052. eCollection 2023 Jul 14.
10
RNAi for the Treatment of People with Hemophilia: Current Evidence and Patient Selection.RNA干扰用于治疗血友病患者:当前证据与患者选择
J Blood Med. 2023 Apr 22;14:317-327. doi: 10.2147/JBM.S390521. eCollection 2023.